🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Breast cancer ranks first among cancer types seen in women in o...
Status
Completed
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT04729647
Treatments Being Tested
Chronic kidney disease (CKD), is characterized by accelerated development o...
Status
Completed
Location
Poznan University of Medical Sciences
Start Date
2016-03-25
Trial ID
NCT05214872
Treatments Being Tested
In this phase 1 open label study for patients with type I punctate palmopla...
Status
Completed
Location
Soroka Medical Center
Start Date
2022-07-17
Trial ID
NCT05435638
Treatments Being Tested
The aim of this study is to evaluate systemic inflammation in individuals w...
Status
Completed
Location
Department of Physical Medicine and Rehabilitation, Health Sciences University Sultan Abdulhamid Han Training and Research Hospital
Start Date
2026-06-01
Trial ID
NCT07787234
Treatments Being Tested
This study will evaluate the development of venous thromboembolism (VTE) an...
Status
Unknown
Location
University Hospital of Larissa
Start Date
2023-09-01
Trial ID
NCT05964621
This Phase 1b, open-label, single-center, prospective trial will be assessi...
Status
Completed
Location
Royal London Hospital-Clinical Research Facility-11D (11th Floor) Whitechapel, London, E1 1FR,
Start Date
2023-03-06
Trial ID
NCT05956314
Treatments Being Tested
levated levels of S100B protein are a well-established marker of central ne...
Status
Recruiting
Location
Institute of Mother and Child
Start Date
2024-07-17
Trial ID
NCT06984445
Treatments Being Tested
This study will evaluate the impact of complex thoraco-abdominal aortic ane...
Status
Recruiting
Location
Larissa University Hospital
Start Date
2024-12-31
Trial ID
NCT06432387
Treatments Being Tested
Hematological inflammatory indices (Table 2) are currently very popular and...
Status
Completed
Location
Volkan Şah
Start Date
2023-01-09
Trial ID
NCT06432530
Recently, European Medicines Agency approved ibrutinib and idelalisib to tr...
Status
Completed
Location
Cancer University Institute of Toulouse Oncopole
Start Date
2016-04
Trial ID
NCT02824159